Segura, Javier H. et al. published their research in Plant and Soil in 2019 |CAS: 517-23-7

The Article related to boreal tree species soil organic matter saprotrophic mineralization, Fertilizers, Soils, and Plant Nutrition: Soil Composition, Fertility, and Physicochemistry and other aspects.Quality Control of 3-Acetyldihydrofuran-2(3H)-one

On August 31, 2019, Segura, Javier H.; Nilsson, Mats B.; Sparrman, Tobias; Serk, Henrik; Schleucher, Jurgen; Tolu, Julie; Oequist, Mats G. published an article.Quality Control of 3-Acetyldihydrofuran-2(3H)-one The title of the article was Boreal tree species affect soil organic matter composition and saprotrophic mineralization rates. And the article contained the following:

To investigate how different tree species affect the composition of SOM and its mineralization in boreal forest ecosystems. We used pyrolysis GC-MS for mol.-level characterization of the SOM formed under five common boreal tree species at a replicated field experiment �0years after plantation. We incubated soil samples at 4, 9, 14 and 19°C and measured inherent CO2 production and substrate-induced respiration. We then evaluated if the saprotrophic microbial activity and its temperature sensitivity was controlled by the SOM composition The mol. composition of the SOM emerged as key factor influencing SOM properties in plots with different tree species. Most of the variance in the SOM content was explained by the organo-chem. composition of the SOM. More importantly, the fraction of the microbial community able to utilize the native SOM was largely controlled by the SOM organo-chem. composition Temperature sensitivity of CO2 production (Q10) was not explained by SOM composition However, the microbial access to different SOM pools varied with temperature These results bridge the gap between the paradigms of short-term litter and long-term SOM decomposition showing that, on an intermediate timescale (�0 years), boreal tree species affect SOM mol. composition and saprotrophic mineralization rates. The experimental process involved the reaction of 3-Acetyldihydrofuran-2(3H)-one(cas: 517-23-7).Quality Control of 3-Acetyldihydrofuran-2(3H)-one

The Article related to boreal tree species soil organic matter saprotrophic mineralization, Fertilizers, Soils, and Plant Nutrition: Soil Composition, Fertility, and Physicochemistry and other aspects.Quality Control of 3-Acetyldihydrofuran-2(3H)-one

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Lu, Shoufu et al. published their patent in 2011 |CAS: 1198284-94-4

The Article related to diazaspirocyclic compound preparation, Heterocyclic Compounds (One Hetero Atom): Spiro Compounds With One Hetero Atom In Each Ring and other aspects.HPLC of Formula: 1198284-94-4

On December 7, 2011, Lu, Shoufu; Yu, Xinmin published a patent.HPLC of Formula: 1198284-94-4 The title of the patent was Method for preparing diazaspirocyclic compounds. And the patent contained the following:

The invention relates to a process for the preparation of diazaspirocyclic compounds (e.g., I). For instance, substitution of compound II with 1-bromo-3-chloro-propane followed by azidation, heterocyclization, and reduction gave compound I as a white solid. The experimental process involved the reaction of tert-Butyl 1-oxo-2,9-diazaspiro[5.5]undecane-9-carboxylate(cas: 1198284-94-4).HPLC of Formula: 1198284-94-4

The Article related to diazaspirocyclic compound preparation, Heterocyclic Compounds (One Hetero Atom): Spiro Compounds With One Hetero Atom In Each Ring and other aspects.HPLC of Formula: 1198284-94-4

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Yashima, Takumi et al. published their research in Scientific Reports in 2022 |CAS: 118-55-8

The Article related to filamentous crystal growth organic liquid morphol, Crystallography and Liquid Crystals: Crystal Morphology (Habit), Orientation, Crystallinity and other aspects.HPLC of Formula: 118-55-8

On December 31, 2022, Yashima, Takumi; Tani, Marie; Kurita, Rei published an article.HPLC of Formula: 118-55-8 The title of the article was Filamentous crystal growth in organic liquids and selection of crystal morphology. And the article contained the following:

Filamentous crystals such as whisker crystals are often seen not only in metallic liquids, but also in organic liquids and solutions They are interesting as reinforce materials. However, it remains challenging to induce filamentous crystals due to an incomplete understanding of the mechanisms behind their formation. In this paper, we investigate filamentous crystal growth in viscous organic liquids It is found that filamentous crystals grow via an extraordinary dynamical path, where the mols. locally evaporate to bubbles and then redeposite to the tip of growing crystalline filaments. We also succeeded in controlling whether filamentous or faceted crystal growth is selected by inducing or suppressing the bubbles. The experimental process involved the reaction of Phenyl Salicylate(cas: 118-55-8).HPLC of Formula: 118-55-8

The Article related to filamentous crystal growth organic liquid morphol, Crystallography and Liquid Crystals: Crystal Morphology (Habit), Orientation, Crystallinity and other aspects.HPLC of Formula: 118-55-8

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Pasternak, Alexander et al. published their patent in 2016 |CAS: 1198284-94-4

The Article related to spiropiperidine azacycle preparation romk channel inhibitor, Heterocyclic Compounds (One Hetero Atom): Spiro Compounds With One Hetero Atom In Each Ring and other aspects.Related Products of 1198284-94-4

On May 6, 2016, Pasternak, Alexander; Dong, Shuzhi; Gu, Xin; Jiang, Jinlong; Shi, Zhi-Cai; Walsh, Shawn P.; Wu, Zhicai; Yu, Yang; Ferguson, Ronald, II; Guo, Zhiqiang; Frie, Jessica; Suzuki, Takao; Blizzard, Timothy A.; Fu, Qinghong; Vangelder, Kelsey F. published a patent.Related Products of 1198284-94-4 The title of the patent was Spiro[piperidine-azacycle] derivatives as inhibitors of the renal outer medullary potassium channel and their preparation. And the patent contained the following:

The invention provides compounds of formula I and pharmaceutically acceptable salts thereof, which are inhibitor of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention. Compounds of formula I wherein A is CH2, CH2CH2 and CH2CH2CH2; B is CH2 and CH2; X is (un)substituted 4-(tetrazol-1-yl)phenyl, (un)substituted oxoisobenzofuranyl, (un)substituted (tetrazol-1-yl)pyridinyl, etc.; Y is O, NH and a bond; Z is (un)substituted Ph, (un)substituted pyridinyl, (un)substituted pyrimidinyl, etc.; n is 0, 1 and 2; R1 is H, D and OH; R2 is H and D; R3 is H, D and alkyl; R4 is H and D; each R5 is independently oxo and (un)substituted alkyl; and pharmaceutically acceptable salts thereof, are claimed. Example compound II was prepared by arylation of 5-[(1R)-2-(2,8-diazaspiro[4.5]dec-8-yl)-1-hydroxyethyl]-4-methyl-2-benzofuran-1(3H)-one with 5-chloro-3-methyl-1,2,4-thiadiazole. The invention compounds were evaluated for their ROMK channel inhibitory activity. From the assay, it was determined that compound II exhibited IC50 value of 0.2508 μM. The experimental process involved the reaction of tert-Butyl 1-oxo-2,9-diazaspiro[5.5]undecane-9-carboxylate(cas: 1198284-94-4).Related Products of 1198284-94-4

The Article related to spiropiperidine azacycle preparation romk channel inhibitor, Heterocyclic Compounds (One Hetero Atom): Spiro Compounds With One Hetero Atom In Each Ring and other aspects.Related Products of 1198284-94-4

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Pasternak, Alexander et al. published their patent in 2016 |CAS: 1198284-94-4

The Article related to spiropiperidine azacycle preparation romk channel inhibitor, Heterocyclic Compounds (One Hetero Atom): Spiro Compounds With One Hetero Atom In Each Ring and other aspects.Recommanded Product: tert-Butyl 1-oxo-2,9-diazaspiro[5.5]undecane-9-carboxylate

On May 6, 2016, Pasternak, Alexander; Dong, Shuzhi; Gu, Xin; Jiang, Jinlong; Shi, Zhi-Cai; Walsh, Shawn P.; Wu, Zhicai; Yu, Yang; Ferguson, Ronald, II; Guo, Zhiqiang; Frie, Jessica; Suzuki, Takao; Blizzard, Timothy A.; Fu, Qinghong; Vangelder, Kelsey F. published a patent.Recommanded Product: tert-Butyl 1-oxo-2,9-diazaspiro[5.5]undecane-9-carboxylate The title of the patent was Spiro[piperidine-azacycle] derivatives as inhibitors of the renal outer medullary potassium channel and their preparation. And the patent contained the following:

The invention provides compounds of formula I and pharmaceutically acceptable salts thereof, which are inhibitor of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention. Compounds of formula I wherein A is CH2, CH2CH2 and CH2CH2CH2; B is CH2 and CH2; X is (un)substituted 4-(tetrazol-1-yl)phenyl, (un)substituted oxoisobenzofuranyl, (un)substituted (tetrazol-1-yl)pyridinyl, etc.; Y is O, NH and a bond; Z is (un)substituted Ph, (un)substituted pyridinyl, (un)substituted pyrimidinyl, etc.; n is 0, 1 and 2; R1 is H, D and OH; R2 is H and D; R3 is H, D and alkyl; R4 is H and D; each R5 is independently oxo and (un)substituted alkyl; and pharmaceutically acceptable salts thereof, are claimed. Example compound II was prepared by arylation of 5-[(1R)-2-(2,8-diazaspiro[4.5]dec-8-yl)-1-hydroxyethyl]-4-methyl-2-benzofuran-1(3H)-one with 5-chloro-3-methyl-1,2,4-thiadiazole. The invention compounds were evaluated for their ROMK channel inhibitory activity. From the assay, it was determined that compound II exhibited IC50 value of 0.2508 μM. The experimental process involved the reaction of tert-Butyl 1-oxo-2,9-diazaspiro[5.5]undecane-9-carboxylate(cas: 1198284-94-4).Recommanded Product: tert-Butyl 1-oxo-2,9-diazaspiro[5.5]undecane-9-carboxylate

The Article related to spiropiperidine azacycle preparation romk channel inhibitor, Heterocyclic Compounds (One Hetero Atom): Spiro Compounds With One Hetero Atom In Each Ring and other aspects.Recommanded Product: tert-Butyl 1-oxo-2,9-diazaspiro[5.5]undecane-9-carboxylate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Shershnev, Ivan et al. published their research in Tetrahedron Letters in 2019 |CAS: 517-23-7

The Article related to spirocyclic ketolactone preparation lewis acid catalyst, cyclic ketone diazo butyrolactone buchner curtius schlotterbeck reaction, Heterocyclic Compounds (One Hetero Atom): Spiro Compounds With One Hetero Atom In Each Ring and other aspects.Safety of 3-Acetyldihydrofuran-2(3H)-one

On July 4, 2019, Shershnev, Ivan; Dar’in, Dmitry; Chuprun, Sergey; Kantin, Grigory; Bakulina, Olga; Krasavin, Mikhail published an article.Safety of 3-Acetyldihydrofuran-2(3H)-one The title of the article was The use of α-diazo-γ-butyrolactone in the Buchner-Curtius-Schlotterbeck reaction of cyclic ketones: A facile entry into spirocyclic scaffolds. And the article contained the following:

The first example of the Buchner-Curtius-Schlotterbeck reaction of cyclic ketones with a stabilized cyclic diazo compound partner is described. The approach towards spirocyclic scaffolds has been exemplified with readily available α-diazo-γ-butyrolactone. The reaction proved to be viable with BF3·OEt2 as the preferred catalyst and displayed substantial sensitivity to the size of the cyclic ketone. The experimental process involved the reaction of 3-Acetyldihydrofuran-2(3H)-one(cas: 517-23-7).Safety of 3-Acetyldihydrofuran-2(3H)-one

The Article related to spirocyclic ketolactone preparation lewis acid catalyst, cyclic ketone diazo butyrolactone buchner curtius schlotterbeck reaction, Heterocyclic Compounds (One Hetero Atom): Spiro Compounds With One Hetero Atom In Each Ring and other aspects.Safety of 3-Acetyldihydrofuran-2(3H)-one

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Maejima, Saki et al. published their research in Journal of Organic Chemistry in 2019 |CAS: 10472-24-9

The Article related to olefin cyclic ketone spirolactonization iodine visible light, spirocyclic lactone preparation, iodine visible light spirolactonization mediator, Heterocyclic Compounds (One Hetero Atom): Spiro Compounds With One Hetero Atom In Each Ring and other aspects.Application of 10472-24-9

On August 2, 2019, Maejima, Saki; Yamaguchi, Eiji; Itoh, Akichika published an article.Application of 10472-24-9 The title of the article was Visible Light/Molecular-Iodine-Mediated Intermolecular Spirolactonization Reaction of Olefins with Cyclic Ketones. And the article contained the following:

In this study, intermol. spirolactonization via an iodine/visible-light-mediated C-C/C-O bond formation reaction was developed. The developed reaction proceeded to form quaternary carbon centers via carboesterification between cyclic β-keto esters and olefins, affording spirolactone derivatives, e.g., I, in a single step. In addition, the mechanistic investigation revealed that the generation of iodine radicals from mol. iodine driven by visible-light irradiation is a crucial step. The developed reaction proceeded under milder conditions than previously reported procedures as iodine played a role of a conventional transition-metal catalyst, realizing an environmentally friendly mol. transformation. The experimental process involved the reaction of Methyl 2-cyclopentanonecarboxylate(cas: 10472-24-9).Application of 10472-24-9

The Article related to olefin cyclic ketone spirolactonization iodine visible light, spirocyclic lactone preparation, iodine visible light spirolactonization mediator, Heterocyclic Compounds (One Hetero Atom): Spiro Compounds With One Hetero Atom In Each Ring and other aspects.Application of 10472-24-9

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Grell, Yvonne et al. published their research in Organometallics in 2019 |CAS: 707-07-3

The Article related to bisoxazoline chiral auxiliary enantioselective cyclometalated rhodium complex preparation, crystal structure mol chiral biscyclometalated rhodium complex, Organometallic and Organometalloidal Compounds: Group Viii – Co, Ni, Ru, Rh, Pd, Os, Ir, Pt and other aspects.SDS of cas: 707-07-3

On October 14, 2019, Grell, Yvonne; Demirel, Nemrud; Harms, Klaus; Meggers, Eric published an article.SDS of cas: 707-07-3 The title of the article was Chiral Bis(oxazoline) Ligands as C2-Symmetric Chiral Auxiliaries for the Synthesis of Enantiomerically Pure Bis-Cyclometalated Rhodium(III) Complexes. And the article contained the following:

The synthesis of enantiomerically pure bis-cyclometalated rhodium(III) complexes using chiral bis(oxazoline) ligands as C2-sym. chiral auxiliaries is described. Bis(oxazolines) are versatile chiral ligands for asym. catalysis but have not been applied to the resolution of racemic mixtures of transition-metal complexes. Due to their C2 symmetry, chiral bis(oxazolines) are particularly useful for the synthesis of nonracemic transition-metal complexes with lower symmetry, and this is demonstrated with the synthesis of an enantiomerically pure rhodium(III) complex containing two different cyclometalated ligands. The experimental process involved the reaction of (Trimethoxymethyl)benzene(cas: 707-07-3).SDS of cas: 707-07-3

The Article related to bisoxazoline chiral auxiliary enantioselective cyclometalated rhodium complex preparation, crystal structure mol chiral biscyclometalated rhodium complex, Organometallic and Organometalloidal Compounds: Group Viii – Co, Ni, Ru, Rh, Pd, Os, Ir, Pt and other aspects.SDS of cas: 707-07-3

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Jacolot, Maiwenn et al. published their research in Organic Letters in 2012 |CAS: 3976-69-0

The Article related to crystal mol structure nitro oxaspiro undecanyl benzamide, chiral spiropyran portentol skeleton preparation, dft mechanism calculation prins cyclization ketone, Heterocyclic Compounds (One Hetero Atom): Spiro Compounds With One Hetero Atom In Each Ring and other aspects.Product Details of 3976-69-0

On January 6, 2012, Jacolot, Maiwenn; Jean, Mickael; Levoin, Nicolas; van de Weghe, Pierre published an article.Product Details of 3976-69-0 The title of the article was The Prins Reaction Using Ketones: Rationalization and Application toward the Synthesis of the Portentol Skeleton. And the article contained the following:

We report a TMSI-promoted Prins cyclization reaction with ketones as carbonyl partners to prepare polysubstituted chiral spirotetrahydropyrans. In the presence of racemic 2-methylcyclohexanone a dynamic kinetic resolution occurred affording one stereoisomer. The observed enantiospecificity has been rationalized by DFT calculation The experimental process involved the reaction of (R)-Methyl 3-hydroxybutanoate(cas: 3976-69-0).Product Details of 3976-69-0

The Article related to crystal mol structure nitro oxaspiro undecanyl benzamide, chiral spiropyran portentol skeleton preparation, dft mechanism calculation prins cyclization ketone, Heterocyclic Compounds (One Hetero Atom): Spiro Compounds With One Hetero Atom In Each Ring and other aspects.Product Details of 3976-69-0

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Bellenie, Benjamin Richard et al. published their patent in 2018 |CAS: 1198284-94-4

The Article related to quinolinone diamino derivative preparation inhibitor bcl6 inhibitor cancer, Heterocyclic Compounds (More Than One Hetero Atom): Other 6-Membered Rings, Two Hetero Atoms and other aspects.Safety of tert-Butyl 1-oxo-2,9-diazaspiro[5.5]undecane-9-carboxylate

On November 29, 2018, Bellenie, Benjamin Richard; Cheung, Kwai Ming Jack; Davis, Owen Alexander; Hoelder, Swen; Huckvale, Rosemary; Lloyd, Matthew Garth published a patent.Safety of tert-Butyl 1-oxo-2,9-diazaspiro[5.5]undecane-9-carboxylate The title of the patent was Preparation of 4,6-diamino-quinolin-2(1H)-one derived inhibitors of Bcl6 for treatment of cancer. And the patent contained the following:

The invention relates to compounds of formula I that function as inhibitors of Bcl6 (B-cell lymphoma 6) useful for treatment of disorders involving Bcl6 activity such as proliferative disorders including cancers. Addnl., the invention comprises synthetic processes for the preparation of I and pharmaceutical compositions containing I. Compounds of formula I [wherein X1 = N, CH, C-alkyl, C-halo, etc.; X2 and X3 independently = N, CH, CF, CCl, etc.; R1 = H, CH3, 2-(methoxyethoxy)ethyl, etc.; R2 = 2,3-dichloro-pyridin-4-yl, 2-chloro-4-cyano-pyridin-4-yl, 2-chloro-5-methoxy-pyrimidin-4-yl, etc.; R3 = H, C1-2 alkyl, cyano, etc.; R4 = cyano, C1-4 alkyl, C1-4 haloalkyl, etc.; R5 = H, C1-4 alkyl, cyano, nitro, acetylenyl, Ph, etc.; with provisos] and pharmaceutically acceptable salts or solvates thereof, are claimed and exemplified. Example compound II was prepared from the reaction of 6-amino-1-methyl-4-[(1-methyl-1-pyrimidin-2-ylethyl)amino]quinolin-2-one and 2,4-dichloropyridine-3-carbonitrile under microwave heating for 1 h at 160°C. Pharmacol. activity of I was evaluated using a HTRF assay and Trx-6xHis-Bcl6 derived from the human Bcl6 BRB domain from which II demonstrated a pIC50 value of 7.38 μM. The experimental process involved the reaction of tert-Butyl 1-oxo-2,9-diazaspiro[5.5]undecane-9-carboxylate(cas: 1198284-94-4).Safety of tert-Butyl 1-oxo-2,9-diazaspiro[5.5]undecane-9-carboxylate

The Article related to quinolinone diamino derivative preparation inhibitor bcl6 inhibitor cancer, Heterocyclic Compounds (More Than One Hetero Atom): Other 6-Membered Rings, Two Hetero Atoms and other aspects.Safety of tert-Butyl 1-oxo-2,9-diazaspiro[5.5]undecane-9-carboxylate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics